Restrictive Cardiomyopathy Research This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Genetic profile and genotype-phenotype correlations in childhood cardiomyopathy
CONCLUSIONS: In our population, children with cardiomyopathy had a high positive genetic test rate. Hypertrophic cardiomyopathy with a positive genetic test is associated with a worse outcome.PMID:37246080 | DOI:10.1016/j.acvd.2023.04.008 (Source: Archives of Cardiovascular Diseases)
Source: Archives of Cardiovascular Diseases - May 28, 2023 Category: Cardiology Authors: Chlo é Wanert Fedoua El Louali Sarab Al Dybiat Karine Nguyen St éphane Zaffran Caroline Ovaert Source Type: research

Successful Reuse of a Donor Heart
Tex Heart Inst J. 2023 May 1;50(3):e217726. doi: 10.14503/THIJ-21-7726.ABSTRACTAt a time when transplantable organs are in a shortage, few cases have noted the reuse of donor hearts in a second recipient in an effort to expand the donor network. Here, we present a case in which an O Rh-positive donor heart was first transplanted into a B Rh-positive recipient and later successfully retransplanted into a second O Rh-positive recipient 10 days after the initial transplant at the same medical center. On postoperative day 1, the first recipient, a 21-year-old man with nonischemic cardiomyopathy, sustained a devastating cerebro...
Source: Texas Heart Institute Journal - May 8, 2023 Category: Cardiology Authors: Gabriel Esmailian Qiudong Chen Danny Ramzy Jon A Kobashigawa Joanna Chikwe Fardad Esmailian Source Type: research

Genetic Testing for Cardiomyopathy in Japan 2022: Current Status and Issues of Precision Medicine
The concept of precision medicine has been widely embraced. Advances in molecular genetics over the past 30 years have led to the successive identification of genetic mutations (pathogenic variants) that cause hypertrophic cardiomyopathy (HCM), dilated cardiomyopathy (DCM), restrictive cardiomyopathy, and arrhythmogenic cardiomyopathy (AC), which are all classified as idiopathic or primary cardiomyopathy,1,2 and these are no longer considered diseases of unknown cause. The advances of molecular genetics have been accompanied by advances in an understanding of the pathogenesis of cardiomyopathy, and identification of pathog...
Source: Journal of Cardiac Failure - May 1, 2023 Category: Cardiology Authors: TORU KUBO, HIROAKI KITAOKA Tags: Review Article Source Type: research

Po-05-164 impact of arrhythmias in patients with hemochromatosis: a national inpatient sample (nis) analysis
Hemochromatosis is a relatively rare genetic disease that results in restrictive cardiomyopathy caused by the deposition of iron. Iron has a higher affinity to deposit in the conduction system of the heart resulting in a lower threshold for developing arrhythmias. We sought to assess the data on the burden of arrhythmias in hospitalized patients with hemochromatosis. (Source: Heart Rhythm)
Source: Heart Rhythm - May 1, 2023 Category: Cardiology Authors: Dhairya Nanavaty, Sohrab Singh, Ankushi Sanghvi, Anuj Thakre, Vikash Kumar, Pradeep Kumar Devarakonda, Suganya Manoharan, Saikrishna Patibandla, Dishang Bhavsar, Vishal Dhulipala, Cesar Ayala-Rodriguez, Sarath Reddy, Kannu Bansal Source Type: research

Transthyretin Cardiomyopathy: An Underdiagnosed Pathology, Presenting with Common Geriatric Syndromes
Symptomatology of transthyretin amyloidosis varies with organ involvement, but it almost invariably presents with the common geriatric syndromes. Transthyretin cardiac amyloidosis causes restrictive cardiomyopathy which if not diagnosed and treated early, leads to congestive heart failure (CHF) with poor prognosis. (Source: Journal of the American Medical Directors Association)
Source: Journal of the American Medical Directors Association - April 28, 2023 Category: Health Management Authors: Vanessa Joyce Evardone, Janice Michelle Sarigumba, Jose Socrates Evardone Tags: Poster Abstract Source Type: research

Prevalence of Incidental Amyloid on Cardiac Explants
Cardiac amyloidosis (CA) is an increasingly identified cause of heart failure, particularly restrictive cardiomyopathy, with more patients undergoing orthotopic heart transplant (OHT). CA prevalence is unknown but autopsy studies show CA deposition relatively commonly. In an unselected population CA can be found in 4% of people and in specific high risk populations (ie heart failure with preserved ejection fraction) can be 13-20%. Most studies are in an older population with little data in younger people. (Source: The Journal of Heart and Lung Transplantation)
Source: The Journal of Heart and Lung Transplantation - April 1, 2023 Category: Transplant Surgery Authors: N. Gorrie, P. MacDonald, V. Sivasubramaniam, A. Jabbour, K. Muthiah, D. Fatkin, E. Kotlyar, C. Hayward, N. Bart Tags: (993) Source Type: research

Heart-lung Transplantation for Restrictive Cardiomyopathy and Pulmonary Hypertension Due to Emery-Dreifuss Muscular Dystrophy
A 28-year-old man with Emery-Dreifuss muscular dystrophy (MD) developed restrictive cardiomyopathy (RCM) and pre- and post-capillary pulmonary hypertension (PH), and ultimately underwent successful heart-lung transplantation (HLTx). We believe this is the first reported case of HTLx for this indication. (Source: The Journal of Heart and Lung Transplantation)
Source: The Journal of Heart and Lung Transplantation - April 1, 2023 Category: Transplant Surgery Authors: C. Thomas, K. Klein, J. Kennedy, M. Psotka, I. Isseh, D. Tang, S. Aryal, V. Khangoora, A. Nyquist, A. Singhal, O. Cantres-Fonseca, O. Shlobin, S. Nathan, C. King Tags: (478) Source Type: research

Heart Transplant Outcomes in Restrictive Cardiomyopathy: UNOS Registry Analysis
Restrictive cardiomyopathy comprises diverse etiologies with overall poor prognosis. Emerging therapies have significantly impacted some of these entities. However, these therapies may have limited impact in the end-stages. We sought to assess outcomes following transplant in this population. (Source: The Journal of Heart and Lung Transplantation)
Source: The Journal of Heart and Lung Transplantation - April 1, 2023 Category: Transplant Surgery Authors: D.J. Miklin, E. DePasquale Tags: (89) Source Type: research